Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy

Chatterjee, 2014, Corticosterone targets distinct steps of synaptic transmission via concentration specific activation of mineralocorticoid and glucocorticoid receptors, J. Neurochem., 128, 476, 10.1111/jnc.12478

Rajapandi, 2000, The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor, J. Biol. Chem., 275, 22597, 10.1074/jbc.M002035200

Sinclair, 2012, Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder, BMC Psychiatry, 12, 84, 10.1186/1471-244X-12-84

van Winsen, 2009, A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis, J. Clin. Endocrinol. Metab., 94, 2110, 10.1210/jc.2008-2194

Wang, 2015, Glucocorticoid receptor beta acts as a co-activator of T-cell factor 4 and enhances glioma cell proliferation, Mol. Neurobiol., 52, 1106, 10.1007/s12035-014-8900-9

Hudson, 2018, Cryptic glucocorticoid receptor-binding sites pervade genomic NF-kappaB response elements, Nat. Commun., 9, 1337, 10.1038/s41467-018-03780-1

Weikum, 2017, Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes, Nucleic Acids Res., 45, 8596, 10.1093/nar/gkx509

Ridder, 2005, Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions, J. Neurosci., 25, 6243, 10.1523/JNEUROSCI.0736-05.2005

Martinez-Levy, 2018, Increased expression of brain-derived neurotrophic factor transcripts I and VI, cAMP response element binding, and glucocorticoid receptor in the cortex of patients with temporal lobe epilepsy, Mol. Neurobiol., 55, 3698

Chen, 2017, Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells, Mol. Brain, 10, 12, 10.1186/s13041-017-0295-x

Adachi, 2015, Glucocorticoid affects dendritic transport of BDNF-containing vesicles, Sci. Rep., 5, 12684, 10.1038/srep12684

Spencer, 1998, Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity, Endocrinology, 139, 2718, 10.1210/endo.139.6.6029

Gjerstad, 2018, Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility, Stress, 21, 403, 10.1080/10253890.2018.1470238

ter Heegde, 2015, The brain mineralocorticoid receptor and stress resilience, Psychoneuroendocrinology, 52, 92, 10.1016/j.psyneuen.2014.10.022

Brinks, 2007, Differential MR/GR activation in mice results in emotional states beneficial or impairing for cognition, Neural Plast., 2007, 90163, 10.1155/2007/90163

Ouanes, 2019, High cortisol and the risk of dementia and Alzheimer’s disease: a review of the literature, Front. Aging Neurosci., 10.3389/fnagi.2019.00043

Baes, 2014, Early life stress in depressive patients: HPA axis response to GR and MR agonist, Front. Psychiatry, 5, 2, 10.3389/fpsyt.2014.00002

Kirschke, 2014, Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles, Cell, 157, 1685, 10.1016/j.cell.2014.04.038

Pfaff, 2010, Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled, J. Biol. Chem., 285, 15256, 10.1074/jbc.M110.108118

Son, 2008, Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production, Proc. Natl. Acad. Sci. U. S. A., 105, 20970, 10.1073/pnas.0806962106

Buren, 2007, Hippocampal 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat, Endocrinology, 148, 2716, 10.1210/en.2006-0897

de Kloet, 2018, Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation, Front. Neuroendocrinol., 49, 124, 10.1016/j.yfrne.2018.02.003

Chung, 2011, Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications, Biochim. Biophys. Acta, 1812, 581, 10.1016/j.bbadis.2011.02.003

Garabedian, 2017, Glucocorticoid receptor action in metabolic and neuronal function, F1000Res, 6, 1208, 10.12688/f1000research.11375.1

Yongue, 1987, Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids, Brain Res., 436, 49, 10.1016/0006-8993(87)91555-1

Reul, 1985, Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation, Endocrinology, 117, 2505, 10.1210/endo-117-6-2505

De Kloet, 1987, Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems, Psychoneuroendocrinology, 12, 83, 10.1016/0306-4530(87)90040-0

Kim, 2019, Treadmill exercise alleviates circadian rhythm disruption-induced memory deficits by activation of glucocorticoid receptor and brain-derived neurotrophic factor-dependent pathway, Int. Neurourol. J., 23, 40, 10.5213/inj.1938048.024

Furay, 2006, Region-specific regulation of glucocorticoid receptor/HSP90 expression and interaction in brain, J. Neurochem., 98, 1176, 10.1111/j.1471-4159.2006.03953.x

Biddie, 2011, Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding, Mol. Cell, 43, 145, 10.1016/j.molcel.2011.06.016

Tesikova, 2016, Divergent binding and transactivation by two related steroid receptors at the same response element, J. Biol. Chem., 291, 11899, 10.1074/jbc.M115.684480

Ramamoorthy, 2013, Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements, Mol. Cell Biol., 33, 1711, 10.1128/MCB.01151-12

Jochems, 2015, Enhancement of stress resilience through Hdac6-mediated regulation of glucocorticoid receptor chaperone dynamics, Biol. Psychiatry, 77, 345, 10.1016/j.biopsych.2014.07.036

Weaver, 2004, Epigenetic programming by maternal behavior, Nat. Neurosci., 7, 847, 10.1038/nn1276

Liu, 1997, Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress, Science, 277, 1659, 10.1126/science.277.5332.1659

Plotsky, 2005, Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring, Neuropsychopharmacology, 30, 2192, 10.1038/sj.npp.1300769

McGowan, 2009, Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse, Nat. Neurosci., 12, 342, 10.1038/nn.2270

Rodgers, 2013, Paternal stress exposure alters sperm microRNA content and reprograms offspring HPA stress axis regulation, J. Neurosci., 33, 9003, 10.1523/JNEUROSCI.0914-13.2013

Mueller, 2008, Sex-specific programming of offspring emotionality following stress early in pregnancy, J. Neurosci., 28, 9055, 10.1523/JNEUROSCI.1424-08.2008

Buoso, 2017, Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone, Pharmacol. Res., 120, 180, 10.1016/j.phrs.2017.03.019

Goecke, 2007, Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro, Mol. Immunol., 44, 2115, 10.1016/j.molimm.2006.07.303

Forster, 2006, Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific, J. Physiol., 573, 413, 10.1113/jphysiol.2006.106385

Encio, 1991, The genomic structure of the human glucocorticoid receptor, J. Biol. Chem., 266, 7182, 10.1016/S0021-9258(20)89627-6

Pujols, 2002, Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues, Am. J. Physiol. Cell Physiol., 283, C1324, 10.1152/ajpcell.00363.2001

Oakley, 1996, The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function, J. Biol. Chem., 271, 9550, 10.1074/jbc.271.16.9550

Bamberger, 1995, Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans, J. Clin. Invest., 95, 2435, 10.1172/JCI117943

Fruchter, 2005, The human glucocorticoid receptor (GR) isoform {beta} differentially suppresses GR{alpha}-induced transactivation stimulated by synthetic glucocorticoids, J. Clin. Endocrinol. Metab., 90, 3505, 10.1210/jc.2004-1646

de Lange, 1999, Natural variants of the beta isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids, Mol. Cell. Endocrinol., 153, 163, 10.1016/S0303-7207(99)00072-6

Hecht, 1997, Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor, J. Biol. Chem., 272, 26659, 10.1074/jbc.272.42.26659

de Castro, 1996, The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role, Mol. Med., 2, 597, 10.1007/BF03401643

Abbott, 2002, Astrocyte–endothelial interactions and blood–brain barrier permeability*, J. Anat., 200, 629, 10.1046/j.1469-7580.2002.00064.x

Hue, 2015, Dexamethasone potentiates in vitro blood–brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein, J. Cereb. Blood Flow Metab., 35, 1191, 10.1038/jcbfm.2015.38

Kim, 2008, Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood–brain barrier, Biochem. Biophys. Res. Commun., 372, 243, 10.1016/j.bbrc.2008.05.025

Kleinschnitz, 2011, Glucocorticoid insensitivity at the hypoxic blood–brain barrier can be reversed by inhibition of the proteasome, Stroke, 42, 1081, 10.1161/STROKEAHA.110.592238

Vinukonda, 2010, Effect of prenatal glucocorticoids on cerebral vasculature of the developing brain, Stroke, 41, 1766, 10.1161/STROKEAHA.110.588400

Hou, 2013, Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy, Neurosurg. Focus, 35, E2, 10.3171/2013.8.FOCUS13301

Stanimirovic, 1994, Dexamethasone down-regulates endothelin receptors in human cerebromicrovascular endothelial cells, Neuropeptides, 26, 145, 10.1016/0143-4179(94)90123-6

Limbourg, 2002, Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids, J. Clin. Invest., 110, 1729, 10.1172/JCI0215481

Ghosh, 2018, Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood–brain barrier model, Epilepsia, 59, 2049, 10.1111/epi.14567

Ghosh, 2017, Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells, Epilepsia, 58, 576, 10.1111/epi.13703

Narang, 2008, Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood–brain barrier, Am. J. Physiol. Cell Physiol., 295, C440, 10.1152/ajpcell.00491.2007

Muller, 2003, ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder, Neuropsychopharmacology, 28, 1991, 10.1038/sj.npp.1300257

Meijer, 1998, Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice, Endocrinology, 139, 1789, 10.1210/endo.139.4.5917

Wang, 2016, Glucocorticoid induces incoordination between glutamatergic and GABAergic neurons in the amygdala, PLoS One, 11, e0166535, 10.1371/journal.pone.0166535

Hartmann, 2017, Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor, Mol. Psychiatry, 22, 466, 10.1038/mp.2016.87

Rakotomamonjy, 2011, Novel protective effect of mifepristone on detrimental GABAA receptor activity to immature Purkinje neurons, FASEB J., 25, 3999, 10.1096/fj.11-183384

Kim, 2013, Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors, Comp. Med., 63, 48

Hinkerohe, 2010, Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model, Brain Res., 1329, 45, 10.1016/j.brainres.2010.03.012

Kiefer, 1991, Effects of dexamethasone on microglial activation in vivo: selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus, J. Neuroimmunol., 34, 99, 10.1016/0165-5728(91)90119-R

Unemura, 2012, Glucocorticoids decrease astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo, J. Pharmacol. Sci., 119, 30, 10.1254/jphs.12047FP

Bergsteindottir, 1992, In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules, Proc. Natl. Acad. Sci. U. S. A., 89, 9054, 10.1073/pnas.89.19.9054

Tertil, 2018, Glucocorticoid receptor signaling in astrocytes is required for aversive memory formation, Transl. Psychiatry, 8, 255, 10.1038/s41398-018-0300-x

Butts, 2011, Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function, Proc. Natl. Acad. Sci. U. S. A., 108, 18459, 10.1073/pnas.1111746108

Lee, 2014, Coping and glucocorticoid receptor regulation by stress inoculation, Psychoneuroendocrinology, 49, 272, 10.1016/j.psyneuen.2014.07.020

Izquierdo, 1997, Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats, Eur. J. Neurosci., 9, 786, 10.1111/j.1460-9568.1997.tb01427.x

McKlveen, 2013, Role of prefrontal cortex glucocorticoid receptors in stress and emotion, Biol. Psychiatry, 74, 672, 10.1016/j.biopsych.2013.03.024

Diorio, 1993, The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress, J. Neurosci., 13, 3839, 10.1523/JNEUROSCI.13-09-03839.1993

Noguchi, 2011, Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis, Neurobiol. Dis., 43, 356, 10.1016/j.nbd.2011.04.004

Wenzel, 2001, Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor, Invest. Ophthalmol. Vis. Sci., 42, 1653

Henckens, 2010, Time-dependent effects of corticosteroids on human amygdala processing, J. Neurosci., 30, 12725, 10.1523/JNEUROSCI.3112-10.2010

Karst, 2000, Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers, Nat. Neurosci., 3, 977, 10.1038/79910

Jakovcevski, 2011, Susceptibility to the long-term anxiogenic effects of an acute stressor is mediated by the activation of the glucocorticoid receptors, Neuropharmacology, 61, 1297, 10.1016/j.neuropharm.2011.07.034

Joels, 2004, Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus, Stress, 7, 221, 10.1080/10253890500070005

Geuze, 2012, Glucocorticoid receptor number predicts increase in amygdala activity after severe stress, Psychoneuroendocrinology, 37, 1837, 10.1016/j.psyneuen.2012.03.017

Buwalda, 2001, Temporal and spatial dynamics of corticosteroid receptor down-regulation in rat brain following social defeat, Physiol. Behav., 72, 349, 10.1016/S0031-9384(00)00414-5

Goldwater, 2009, Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery, Neuroscience, 164, 798, 10.1016/j.neuroscience.2009.08.053

Bonanno, 2005, Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus, J. Neurosci., 25, 3270, 10.1523/JNEUROSCI.5033-04.2005

Musazzi, 2010, Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants, PLoS One, 5, 10.1371/annotation/101dd9d3-4e1b-4863-9473-bbfef49c9a1d

Bao, 2011, Changes of glucocorticoid receptor mRNA expression in basolateral amygdale-kindled rats, Chin. Med. J., 124, 2622

Kumar, 2007, The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors, Psychoneuroendocrinology, 32, 834, 10.1016/j.psyneuen.2007.05.011

Wulsin, 2016, RU486 mitigates hippocampal pathology following status epilepticus, Front. Neurol., 7, 214, 10.3389/fneur.2016.00214

Watzka, 2000, Corticosteroid receptor mRNA expression in the brains of patients with epilepsy, Steroids, 65, 895, 10.1016/S0039-128X(00)00205-1

Pascussi, 2003, The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors, Biochim. Biophys. Acta, 1619, 243, 10.1016/S0304-4165(02)00483-X

Pascussi, 2008, The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences, Annu. Rev. Pharmacol. Toxicol., 48, 1, 10.1146/annurev.pharmtox.47.120505.105349

Cooper, 2008, Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression, Toxicol. Sci, 103, 268, 10.1093/toxsci/kfn047

Duret, 2006, Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor, Mol. Pharmacol., 70, 329, 10.1124/mol.105.022046

Ferguson, 2005, Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha, Mol. Pharmacol., 68, 747757, 10.1124/mol.105.013169

Ellemann, 1988, Glucocorticoid receptors in glioblastoma multiforme: a new approach to antineoplastic glucocorticoid therapy, Acta Neurochir., 93, 6, 10.1007/BF01409894

Freshney, 1980, Control of cell proliferation in human glioma by glucocorticoids, Br. J. Cancer, 41, 857, 10.1038/bjc.1980.161

Sinha, 2004, Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study, J. Neurol. Neurosurg. Psychiatry, 75, 1632, 10.1136/jnnp.2003.028647

Kiely, 1994, Glucocorticoids down-regulate beta 1-adrenergic-receptor expression by suppressing transcription of the receptor gene, Biochem. J., 302, 397, 10.1042/bj3020397

Yin, 2013, Glucocorticoid receptor beta regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of beta-catenin/TCF transcriptional activity, Neurobiol. Dis., 59, 165, 10.1016/j.nbd.2013.07.013

Na, 2017, Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells, J. Cereb. Blood Flow Metab., 37, 3695, 10.1177/0271678X17701156

Sherry-Lynes, 2017, Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3, PLoS One, 12, e0174775, 10.1371/journal.pone.0174775

Heiss, 1996, Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor, J. Clin. Invest., 98, 1400, 10.1172/JCI118927

Wetzel, 1995, Glucocorticoid receptor mRNA in Alzheimer’s diseased hippocampus, Brain Res., 679, 72, 10.1016/0006-8993(95)00230-N

Elgh, 2006, Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer’s disease, Biol. Psychiatry, 59, 155, 10.1016/j.biopsych.2005.06.017

Baglietto-Vargas, 2013, Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology, Biol. Psychiatry, 74, 357, 10.1016/j.biopsych.2012.12.003

Sotiropoulos, 2008, Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau, J. Neurochem., 107, 385, 10.1111/j.1471-4159.2008.05613.x

Lante, 2015, Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer’s disease, Neuropsychopharmacology, 40, 1772, 10.1038/npp.2015.25

Michelson, 1994, Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function, J. Clin. Endocrinol. Metab., 79, 848

Melief, 2016, Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis, J. Neuroimmunol., 299, 84, 10.1016/j.jneuroim.2016.08.019

Reder, 1987, Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy, Neurology, 37, 849, 10.1212/WNL.37.5.849

Erkut, 1995, Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis, J. Neuroimmunol., 62, 27, 10.1016/0165-5728(95)00098-M

Bechmann, 2014, Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis, J. Neuroimmunol., 276, 159, 10.1016/j.jneuroim.2014.07.004

Petersen, 2006, Hypothalamic-endocrine aspects in Huntington’s disease, Eur. J. Neurosci., 24, 961, 10.1111/j.1460-9568.2006.04985.x

Bjorkqvist, 2006, Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington’s disease, Hum. Mol. Genet., 15, 1713, 10.1093/hmg/ddl094

Aziz, 2009, Increased hypothalamic-pituitary-adrenal axis activity in Huntington’s disease, J. Clin. Endocrinol. Metab., 94, 1223, 10.1210/jc.2008-2543

Petersen, 2005, Orexin loss in Huntington’s disease, Hum. Mol. Genet., 14, 39, 10.1093/hmg/ddi004

Dufour, 2019, Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of Huntington’s disease, Neurobiol. Dis., 121, 214, 10.1016/j.nbd.2018.09.025

Sapolsky, 1985, Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications, Science, 229, 1397, 10.1126/science.4035356

Magarinos, 1995, Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors, Neuroscience, 69, 89, 10.1016/0306-4522(95)00259-L

Zucchi, 2010, Stress-induced glucocorticoid receptor activation determines functional recovery following ischemic stroke, Exp. Transl. Stroke Med., 2, 18, 10.1186/2040-7378-2-18

Balkaya, 2011, Stress worsens endothelial function and ischemic stroke via glucocorticoids, Stroke, 42, 3258, 10.1161/STROKEAHA.110.607705

Li, 2018, Repression of the glucocorticoid receptor aggravates acute ischemic brain injuries in adult mice, Int. J. Mol. Sci., 19, 2428, 10.3390/ijms19082428

van Haarst, 1996, Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity, Endocrinology, 137, 4935, 10.1210/endo.137.11.8895366

Karssen, 2001, Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain, Endocrinology, 142, 2686, 10.1210/endo.142.6.8213

Boyle, 2005, Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior, Proc. Natl. Acad. Sci. U. S. A., 102, 473, 10.1073/pnas.0406458102

Juruena, 2006, Different responses to dexamethasone and prednisolone in the same depressed patients, Psychopharmacology, 189, 225, 10.1007/s00213-006-0555-4

Paslakis, 2011, Discrimination between patients with melancholic depression and healthy controls: comparison between 24-h cortisol profiles, the DST and the Dex/CRH test, Psychoneuroendocrinology, 36, 691, 10.1016/j.psyneuen.2010.10.002

Boyle, 2006, Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness, J. Neurosci., 26, 1971, 10.1523/JNEUROSCI.2173-05.2006

Calvo, 2001, Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint, Neuroendocrinology, 73, 261, 10.1159/000054643

Wei, 2012, Early-life forebrain glucocorticoid receptor overexpression increases anxiety behavior and cocaine sensitization, Biol. Psychiatry, 71, 224, 10.1016/j.biopsych.2011.07.009

Unlap, 1997, Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo, Brain Res. Mol. Brain Res., 45, 83, 10.1016/S0169-328X(96)00240-9

Unlap, 1994, Dexamethasone attenuates kainate-induced AP-1 activation in rat brain, Brain Res. Mol. Brain Res., 24, 275, 10.1016/0169-328X(94)90140-6

Tsai, 2015, Dexamethasone inhibits brain apoptosis in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection, Parasit. Vectors, 8, 200, 10.1186/s13071-015-0792-7

Girgis, 1989, Dexamethasone treatment for bacterial meningitis in children and adults, Pediatr. Infect. Dis. J., 8, 848, 10.1097/00006454-198912000-00004

de Gans, 2002, Dexamethasone in adults with bacterial meningitis, N. Engl. J. Med., 347, 1549, 10.1056/NEJMoa021334

Tauber, 1985, Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis, J. Infect. Dis., 151, 528, 10.1093/infdis/151.3.528

Hedley-Whyte, 1986, Effect of dexamethasone on blood–brain barrier in the normal mouse, Ann. Neurol., 19, 373, 10.1002/ana.410190411

Meneses, 2017, Intranasal delivery of dexamethasone efficiently controls LPS-induced murine neuroinflammation, Clin. Exp. Immunol., 190, 304, 10.1111/cei.13018

Ong, 2015, Depot delivery of dexamethasone and cediranib for the treatment of brain tumor associated edema in an intracranial rat glioma model, J. Control. Release, 217, 183, 10.1016/j.jconrel.2015.08.028

Jeon, 2015, Dexamethasone-conjugated polyamidoamine dendrimer for delivery of the heme oxygenase-1 gene into the ischemic brain, Macromol. Biosci., 15, 1021, 10.1002/mabi.201500058

Yamada, 1983, Effects of methylprednisolone on peritumoral brain edema. A quantitative autoradiographic study, J. Neurosurg., 59, 612, 10.3171/jns.1983.59.4.0612

Danielson, 2018, Effects of methylprednisolone on blood–brain barrier and cerebral inflammation in cardiac surgery-a randomized trial, J. Neuroinflammation, 15, 283, 10.1186/s12974-018-1318-y

Martinez-Caceres, 2002, Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects, Clin. Exp. Immunol., 127, 165, 10.1046/j.1365-2249.2002.01725.x

Richert, 2001, Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis, Mult. Scler., 7, 49, 10.1177/135245850100700109

Barkhof, 1994, Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis, Neuroradiology, 36, 382, 10.1007/BF00612124

Zivadinov, 2001, Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS, Neurology, 57, 1239, 10.1212/WNL.57.7.1239

de Vargas, 2017, Methylprednisolone as a memory enhancer in rats: effects on aversive memory, long-term potentiation and calcium influx, Brain Res., 1670, 44, 10.1016/j.brainres.2017.06.007

Dos Santos, 2019, High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice, Sci. Rep., 9, 6673, 10.1038/s41598-019-43217-3

Ye, 2011, Ginsenoside Rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window, Neurotherapeutics, 8, 515, 10.1007/s13311-011-0051-3

Hu, 2017, Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression, Eur. J. Pharmacol., 815, 501, 10.1016/j.ejphar.2017.10.019

Sung, 2017, Korean Red Ginseng extract induces angiogenesis through activation of glucocorticoid receptor, J. Ginseng Res., 41, 477, 10.1016/j.jgr.2016.08.011

Ling, 2005, Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor, Gen. Comp. Endocrinol., 140, 203, 10.1016/j.ygcen.2004.11.003

Ghoumari, 2006, Neuroprotective effect of mifepristone involves neuron depolarization, FASEB J., 20, 1377, 10.1096/fj.05-5832com

Belanoff, 2002, An open label trial of C-1073 (mifepristone) for psychotic major depression, Biol. Psychiatry, 52, 386, 10.1016/S0006-3223(02)01432-4

McCullers, 2002, Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat, Neuroscience, 109, 219, 10.1016/S0306-4522(01)00477-8

Check, 2014, Evidence that mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV, Anticancer Res., 34, 2385

Lei, 2014, Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia, PLoS One, 9, 10.1371/journal.pone.0103969

Wang, 2012, Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo, Stem Cells, 30, 169, 10.1002/stem.1000

Nguyen, 2017, A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats, Physiol. Behav., 178, 82, 10.1016/j.physbeh.2017.01.020

Solomon, 2014, The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test, Horm. Behav., 65, 363, 10.1016/j.yhbeh.2014.02.002

Szmulewitz, 2019

Moraitis, 2019

Hunt, 2018, Assessment of safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT125134: an adaptive, double‐blind, randomized, placebo‐controlled Phase 1 clinical study, Clin. Pharmacol. Drug Dev., 7, 408, 10.1002/cpdd.389

Hunt, 2017, J. Med. Chem., 60, 3405, 10.1021/acs.jmedchem.7b00162

Fabbri, 2018, Pleiotropic genes in psychiatry: calcium channels and the stress-related FKBP5 gene in antidepressant resistance, Prog. Neuropsychopharmacol. Biol. Psychiatry, 81, 203, 10.1016/j.pnpbp.2017.10.005

Xu, 2019, Ginsenoside Rg1 protects against H2O2induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro, Int. J. Mol. Med., 43, 717

Foroutan, 1996, Effects of methylprednisolone on the GABA- and glutamate-induced currents: relevance to glucocorticoid-induced neurotoxicity and brain aging, Steroids, 61, 354, 10.1016/0039-128X(96)00041-4

Lopez, 2008, LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo, Endocrinology, 149, 2080, 10.1210/en.2007-1353

Sun, 2016, Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra, J. Steroid Biochem. Mol. Biol., 155, 94, 10.1016/j.jsbmb.2015.09.040

Wang, 2017, Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro, Front. Mol. Neurosci., 10, 441, 10.3389/fnmol.2017.00441

Chen, 2019, Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice, Eur. J. Pharmacol., 856, 172418, 10.1016/j.ejphar.2019.172418

Liu, 2008, Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes, Glia, 56, 1390, 10.1002/glia.20706

Lee, 2008, Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury, J. Neurosci., 28, 3141, 10.1523/JNEUROSCI.5547-07.2008

Zong, 2012, Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory responses via the phospholipase C-gamma1 signaling pathway in murine BV-2 microglial cells, Curr. Med. Chem., 19, 770, 10.2174/092986712798992066

Schmitt, 2006, Methylprednisolone attenuates hypothermia- and rewarming-induced cytotoxicity and IL-6 release in isolated primary astrocytes, neurons and BV-2 microglia cells, Neurosci. Lett., 404, 309, 10.1016/j.neulet.2006.05.064

Katychev, 2003, Glucocorticoid-induced apoptosis in CNS microvascular pericytes, Dev. Neurosci., 25, 436, 10.1159/000075669

Araki, 2006, Efficacy of dexamathasone on cerebral swelling and seizures during subdural grid EEG recording in children, Epilepsia, 47, 176, 10.1111/j.1528-1167.2006.00384.x

Almaabdi, 2014, Intravenous methylprednisolone for intractable childhood epilepsy, Pediatr. Neurol., 50, 334, 10.1016/j.pediatrneurol.2013.12.015

Pera, 2015, Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy, Funct. Neurol., 30, 173

Forster, 2008, Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood–brain barrier, J. Physiol., 586, 1937, 10.1113/jphysiol.2007.146852

Green, 1968, Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol, Nature, 220, 1095, 10.1038/2201095a0

Lee, 2016, Korean Red Ginseng and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells, Mol. Neurobiol., 53, 1977, 10.1007/s12035-015-9131-4

Young, 2004, Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder, Neuropsychopharmacology, 29, 1538, 10.1038/sj.npp.1300471

Brown, 2001, Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review, Bipolar Disord., 3, 23, 10.1034/j.1399-5618.2001.030103.x

Shirakawa, 2006, Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons, Br. J. Pharmacol., 147, 729, 10.1038/sj.bjp.0706636

Quiros, 2008, Melatonin prevents glucocorticoid inhibition of cell proliferation and toxicity in hippocampal cells by reducing glucocorticoid receptor nuclear translocation, J. Steroid Biochem. Mol. Biol., 110, 116, 10.1016/j.jsbmb.2008.02.009

Wei, 2016, Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression, Am. J. Transl. Res., 8, 1910

Zeng, 2010, Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways, Int. Immunopharmacol., 10, 668, 10.1016/j.intimp.2010.03.010

Chen, 2016, A prospective study of dexamethasone therapy in refractory epileptic encephalopathy with continuous spike-and-wave during sleep, Epilepsy Behav., 55, 1, 10.1016/j.yebeh.2015.10.003